[go: up one dir, main page]

AR032138A1 - DERIVATIVES OF 6-HYDROXY-INDAZOL, AN OPHTHALMIC COMPOSITION, AND THE USE OF SUCH DERIVATIVES FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF GLAUCOMA - Google Patents

DERIVATIVES OF 6-HYDROXY-INDAZOL, AN OPHTHALMIC COMPOSITION, AND THE USE OF SUCH DERIVATIVES FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF GLAUCOMA

Info

Publication number
AR032138A1
AR032138A1 ARP000106394A ARP000106394A AR032138A1 AR 032138 A1 AR032138 A1 AR 032138A1 AR P000106394 A ARP000106394 A AR P000106394A AR P000106394 A ARP000106394 A AR P000106394A AR 032138 A1 AR032138 A1 AR 032138A1
Authority
AR
Argentina
Prior art keywords
derivatives
glaucoma
hydroxy
manufacture
treatment
Prior art date
Application number
ARP000106394A
Other languages
Spanish (es)
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of AR032138A1 publication Critical patent/AR032138A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describen derivados de 6-hidroxi-indazoles representado por la formula (1), en donde R1 a R9 tienen su significado dado en la memoria descriptiva; composiciones farmacéuticas que los comprenden y el uso de los mismos para la manufactura de un medicamento utiles para disminuir y controlar la PIO, y para el tratamiento de glaucoma.Derivatives of 6-hydroxy-indazoles represented by formula (1) are described, wherein R1 to R9 have their meaning given in the specification; pharmaceutical compositions that comprise them and the use thereof for the manufacture of a medicament useful for reducing and controlling IOP, and for the treatment of glaucoma.

ARP000106394A 2000-03-17 2000-12-01 DERIVATIVES OF 6-HYDROXY-INDAZOL, AN OPHTHALMIC COMPOSITION, AND THE USE OF SUCH DERIVATIVES FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF GLAUCOMA AR032138A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19038000P 2000-03-17 2000-03-17

Publications (1)

Publication Number Publication Date
AR032138A1 true AR032138A1 (en) 2003-10-29

Family

ID=22701093

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000106394A AR032138A1 (en) 2000-03-17 2000-12-01 DERIVATIVES OF 6-HYDROXY-INDAZOL, AN OPHTHALMIC COMPOSITION, AND THE USE OF SUCH DERIVATIVES FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF GLAUCOMA

Country Status (14)

Country Link
EP (1) EP1268438A1 (en)
JP (1) JP2003528085A (en)
KR (1) KR20030065304A (en)
CN (1) CN1450994A (en)
AR (1) AR032138A1 (en)
AU (1) AU2001216072A1 (en)
BR (1) BR0017157A (en)
CA (1) CA2402403A1 (en)
GC (1) GC0000155A (en)
MX (1) MXPA02008547A (en)
PL (1) PL358481A1 (en)
TW (1) TWI221839B (en)
WO (1) WO2001070702A1 (en)
ZA (1) ZA200206851B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960579B1 (en) 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
TW593302B (en) 2001-12-20 2004-06-21 Alcon Inc Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
WO2003057213A2 (en) * 2001-12-28 2003-07-17 Bayer Pharmaceuticals Corporation Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptor
CA2505127A1 (en) 2002-11-08 2004-05-27 James B. Doherty Ophthalmic compositions for treating ocular hypertension
CN100384827C (en) * 2002-11-08 2008-04-30 默克公司 Ophthalmic composition for the treatment of ocular hypertension
US7196082B2 (en) 2002-11-08 2007-03-27 Merck & Co. Inc. Ophthalmic compositions for treating ocular hypertension
US7053085B2 (en) 2003-03-26 2006-05-30 Merck & Co. Inc. EP4 receptor agonist, compositions and methods thereof
WO2004054572A2 (en) 2002-12-13 2004-07-01 Alcon, Inc. Novel benzopyran analogs and their use for the treatment of glaucoma
JP2004262812A (en) * 2003-02-28 2004-09-24 Rohto Pharmaceut Co Ltd Ocular hypotensive
CA2537119A1 (en) 2003-09-02 2005-03-10 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
AU2004271978B2 (en) 2003-09-04 2009-02-05 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
WO2005026128A1 (en) 2003-09-04 2005-03-24 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
US7338972B1 (en) 2003-12-15 2008-03-04 Alcon, Inc. Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
US7129257B1 (en) 2003-12-15 2006-10-31 Alcon, Inc. Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
US6989445B2 (en) 2003-12-15 2006-01-24 Alcon, Inc. Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma
US7563816B2 (en) 2004-07-20 2009-07-21 Merck & Co. Inc. Ophthalmic compositions for treating ocular hypertension
MX2007006408A (en) 2004-11-29 2007-06-22 Warner Lambert Co Therapeutic pyrazolo[3,4-b] pyridines and indazoles.
US7425572B2 (en) 2004-12-08 2008-09-16 Alcon, Inc. Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
CN101704785B (en) * 2009-11-16 2012-02-29 东南大学 Organic dicarboxylic acid and its salt and preparation method thereof
CN105884687B (en) * 2016-04-14 2018-06-22 梯尔希(南京)药物研发有限公司 A kind of preparation method of 5- benzyls benzydamine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3978899A (en) * 1998-05-19 1999-12-06 Alcon Laboratories, Inc. Serotonergic 5HT, receptor compounds for treating ocular and CNS disorders
ATE247963T1 (en) * 1998-05-26 2003-09-15 Pfizer Prod Inc DRUG FOR TREATING GLAUCOMA AND ISCHEMIC RETINOPATHY
GB9819032D0 (en) * 1998-09-01 1998-10-28 Cerebrus Ltd Chemical compounds IV
TR200100754T2 (en) * 1998-09-18 2001-10-22 Alcon Laboratories, Inc. Serotonergic 5HT2 for treating glaucoma.
GB9820767D0 (en) * 1998-09-23 1998-11-18 Cerebrus Ltd Chemical compounds VIII

Also Published As

Publication number Publication date
CA2402403A1 (en) 2001-09-27
CN1450994A (en) 2003-10-22
AU2001216072A1 (en) 2001-10-03
MXPA02008547A (en) 2003-03-12
BR0017157A (en) 2002-11-26
WO2001070702A1 (en) 2001-09-27
EP1268438A1 (en) 2003-01-02
JP2003528085A (en) 2003-09-24
GC0000155A (en) 2005-06-29
KR20030065304A (en) 2003-08-06
ZA200206851B (en) 2003-10-21
PL358481A1 (en) 2004-08-09
TWI221839B (en) 2004-10-11

Similar Documents

Publication Publication Date Title
AR032138A1 (en) DERIVATIVES OF 6-HYDROXY-INDAZOL, AN OPHTHALMIC COMPOSITION, AND THE USE OF SUCH DERIVATIVES FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF GLAUCOMA
AR020001A1 (en) ACTIVATING COMPOUNDS OF hPPARGAMMA AND hPPARALFA, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, METHOD FOR THE TREATMENT AND / OR PREVENTION OF A DISEASE MEDIATED BY THE SAME, AND ITS USE FOR THE PREPARATION OF A MEDICINAL PRODUCT
BR0108395A (en) Pyrrolopyrimidinone derivatives, preparation and use processes
BRPI0408690A (en) compound, method for treating a disease, pharmaceutical composition, and use of a compound
AR063555A1 (en) DERIVATIVES OF ANDROSTANO, ITS USE IN THE MANUFACTURE OF MEDICINES, PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND AND PROCESSES TO PREPARE THEM
ECSP066313A (en) DERIVATIVES OF PIRIDAZINE AND ITS USE AS THERAPEUTIC AGENTS
ECSP066315A (en) DERIVATIVES OF PIRIDAZINE AND ITS USE AS THERAPEUTIC AGENTS
EE200300033A (en) Cyclopentanoindoles, their use in the preparation of a medicament, and the pharmaceutical composition containing them
CY1114048T1 (en) Combination of brimonidine and timolol for topical ophthalmic use
ECSP066312A (en) PIRIDILO DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS
AR024227A1 (en) INHIBITING PYRIMIDINES OF HIV REPLICATION, A PROCESS FOR PREPARATION, THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITIONS, AND A PROCESS TO PREPARE THEM
ECSP034732A (en) DERIVATIVE OF PHENETHANOLAMINE FOR THE TREATMENT OF RESPIRATORY DISEASES
DK2314582T3 (en) Heterocyclic compounds as antiviral agents
NO20011721D0 (en) N-aralkylaminotetralins as ligands for neuropeptide Y Y5 receptor
BR0311337A (en) Ophthalmic use of roflumilast for the treatment of eye diseases.
CU23208A3 (en) OXAZOLIDINONAS REPLACED AND ITS USE IN THE FIELD OF THE SANGUINEA COAGULATION
DOP2009000155A (en) DERIVATIVES OF FITTED HETERO-PENTACICLO-FENILO, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS AND USES TO PREPARE A USEFUL MEDICINAL PRODUCT FOR THE TREATMENT OF A CONDITION MEDIATED BY P38
AR013506A1 (en) USE OF A PHARMACEUTICAL COMPOSITION FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO BE USED IN THE TREATMENT OF DISEASES OF PULMONARCHRONIC OBSTRUCTION AND OF A KIT INCLUDING FORMOTEROL OR A SALT OR SOLVATE OF THE SAME AND BUDESONIDE
GT200600163A (en) NEW THERAPEUTIC COMBINATIONS FOR THE TREATMENT OR PREVENTION OF DEPRESSION
ATE386725T1 (en) HETEROCYCLYL COMPOUNDS
UY29085A1 (en) PIRIMIDINE DERIVATIVES 4-SULFONAMID SUBSTITUTED, INTERMEDIATE COMPOUNDS FOR PREPARATION, PREPARATION PROCEDURES, MEDICINAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS
AR009028A1 (en) PHARMACEUTICAL COMPOSITIONS, A PROCEDURE FOR PREPARING SUCH COMPOSITIONS AND USE OF SUCH COMPOSITIONS IN THE TREATMENT OF OPHTHALMIC DISEASES AND METHODS FOR TREATING SUCH DISEASES
UY27018A1 (en) PIRIMIDINE DERIVATIVES
SE0102055D0 (en) New Compounds
ES2173883T3 (en) USE OF PIPERACINE-ACETAMIDE DERIVATIVES AGAINST REPERFUSION DAMAGES.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal